Israeli biopharma firm BiomX raises $32 million in private funding

Israeli biopharma firm BiomX said on Wednesday it raised $32 million in a private funding round that will primarily be used to advance the company's drug candidates for the treatment of acne and inflammatory bowel disease (IBD).

from Reuters: Health News https://ift.tt/2T4bGVV
via IFTTT